Lv5
1328 积分 2025-04-11 加入
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
1个月前
已完结
Short‐term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al
3个月前
已完结
Efficacy and safety of SGLT2 inhibitors in preventing cardiovascular and renal events in patients with systemic lupus erythematosus and type 2 diabetes: comment on the article by Ma et al
3个月前
已完结
Management of IL ‐17 inhibitors‐induced paradoxical eczema in patients with plaque psoriasis
3个月前
已完结
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
4个月前
已完结
Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria
4个月前
已完结
Chronic Spontaneous Urticaria
4个月前
已完结
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
6个月前
已完结
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
6个月前
已完结
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
6个月前
已完结
皖公网安备34019202002308
